Arca
Skip to content

EVOL® -SI Joint Fusion System

Sacroiliac Joint Fixation. 510(k) K190025, from Cutting Edge Spine, LLC (Waxhaw, NC). Product code OUR, class 2.

As of Nov 16, 2026, K190025 is an FDA 510(k) held by Cutting Edge Spine, LLC, substantially equivalent on Aug 12, 2019 after 217 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Aug 12, 2019
  • Review time: 217 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The EVOL® -SI Joint Fusion System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Other OUR Clearances

The newest 510(k)s for the same product code; their median review was 110 days; see every OUR device

Record

Type
Traditional
Received
Jan 7, 2019
Review panel
Orthopedic
Regulation
21 CFR 888.3040

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.